194
Views
0
CrossRef citations to date
0
Altmetric
Review

Provider-directed analgesia for dental pain

&
Pages 435-451 | Received 03 Mar 2023, Accepted 19 Apr 2023, Published online: 26 Apr 2023

References

  • Bui CH, Seldin EB, Dodson TB. Types, frequencies, and risk factors for complications after third molar extraction. J Oral Maxillofac Surg. 2003 Dec;61(12):1379–1389.
  • Friedman JW. The prophylactic extraction of third molars: a public health hazard. Am J Public Health. 2007 Sep;97(9):1554–1559.
  • Ridgway D. Analgesics for acute pain: meeting the United States food and drug administration’s requirements for proof of efficacy. Clin J Pain. 2004 May;20(3):123–132.
  • Cooper SA, Desjardins PJ. The value of the dental impaction pain model in drug development. Methods Mol Biol. 2010;617:175–190.
  • Pergolizzi JV, Magnusson P, LeQuang JA, et al. The pharmacological management of dental pain. Expert Opin Pharmacother. 2020 Apr;21(5):591–601. DOI:10.1080/14656566.2020.1718651
  • Plesh O, Gansky SA, Curtis DA, et al. The relationship between chronic facial pain and a history of trauma and surgery. Oral Surg, Oral Med Oral Pathol Oral Radiol Endod. 1999 Jul;88(1):16–21.
  • White RP Jr., Shugars DA, Shafer DM, et al. Recovery after third molar surgery: clinical and health-related quality of life outcomes. J Oral Maxillofac Surg. 2003 May;61(5):535–544.
  • Tompach PC, Wagner CL, Sunstrum AB, et al. Investigation of an opioid prescribing protocol after third molar extraction procedures. J Oral Maxillofac Surg. 2019 Apr;77(4):705–714.
  • Cooper SA, Desjardins PJ, Bertoch T, et al. Analgesic efficacy of naproxen sodium versus hydrocodone/acetaminophen in acute postsurgical dental pain: a randomized, double-blind, placebo-controlled trial. Postgrad Med. 2022 Jun;134(5):463–470.
  • Cooper SA, Engel J, Ladov M, et al. Analgesic efficacy of an ibuprofen-codeine combination. Pharmacotherapy. 1982 May;2(3):162–167.
  • Moore PA, Dionne RA, Cooper SA, et al. Why do we prescribe vicodin? J Am Dent Assoc. 2016 Jul;147(7):530–533.
  • Huecker MR, Azadfard M, Leaming JM. Opioid addiction. StatPearls. 2019; Treasure Island (FL).
  • Rudd RA, Aleshire N, Zibbell JE, et al. Increases in drug and opioid overdose deaths–United States, 2000-2014. MMWR Morb Mortal Wkly Rep. 2016 Jan 1;64(50–51):1378–1382. DOI:10.15585/mmwr.mm6450a3
  • Rudd RA, Seth P, David F, et al. Increases in drug and opioid-involved overdose deaths - United States, 2010-2015. MMWR Morb Mortal Wkly Rep. 2016 Dec 30;65(50–51):1445–1452.
  • Gupta N, Vujicic M, Blatz A. Opioid prescribing practices from 2010 through 2015 among dentists in the United States: what do claims data tell us? J Am Dent Assoc. 2018 Apr;149(4):237–245 e236.
  • McCabe SE, West BT, Boyd CJ. Leftover prescription opioids and nonmedical use among high school seniors: a multi-cohort national study. J Adolesc Health. 2013 Apr;52(4):480–485.
  • Schroeder AR, Dehghan M, Newman TB, et al. Association of opioid prescriptions from dental clinicians for us adolescents and young adults with subsequent opioid use and abuse. JAMA Intern Med. 2019 Feb 1;179(2):145–152.
  • Pogatzki-Zahn EM, Segelcke D, Schug SA. Postoperative pain-from mechanisms to treatment. Pain Rep. 2017 Mar;2(2):e588.
  • Pozzi A, Gallelli L. Pain management for dentists: the role of ibuprofen. Ann Stomatol (Roma). 2011 Jul;2(3–4 Suppl):3–24.
  • Amadio P Jr. Peripherally acting analgesics. Am j med 1984 Sep 10;77(3A):17–26.
  • Ohashi N, Kohno T. Analgesic effect of acetaminophen: a review of known and novel mechanisms of action. Front Pharmacol. 2020;11:580289. DOI:10.3389/fphar.2020.580289
  • Konturek SJ, Brzozowski T, Piastucki I, et al. Role of locally generated prostaglandins in adaptive gastric cytoprotection. Dig Dis Sci. 1982 Nov;27(11):967–971.
  • Konturek SJ, Kwiecien N, Obtulowicz W, et al. Effect of carprofen and indomethacin on gastric function, mucosal integrity and generation of prostaglandins in men. Hepatogastroenterology. 1982 Dec;29(6):267–270.
  • Lucas GNC, Leitao ACC, Alencar RL, et al. Pathophysiological aspects of nephropathy caused by non-steroidal anti-inflammatory drugs. J Bras Nefrol. 2019 Jan;41(1):124–130.
  • Amar PJ, Schiff ER. Acetaminophen safety and hepatotoxicity–where do we go from here? Expert Opin Drug Saf. 2007 Jul;6(4):341–355.
  • Ghanem CI, Perez MJ, Manautou JE, et al. Acetaminophen from liver to brain: new insights into drug pharmacological action and toxicity. Pharmacol Res. 2016 Jul;109:119–131.
  • Bertolini A, Ferrari A, Ottani A, et al. Paracetamol: new vistas of an old drug. CNS Drug Rev. 2006;12(3–4):250–275. DOI:10.1111/j.1527-3458.2006.00250.x. Fall-Winter.
  • Boutaud O, Aronoff DM, Richardson JH, et al. Determinants of the cellular specificity of acetaminophen as an inhibitor of prostaglandin H(2) synthases. Proc Natl Acad Sci U S A. 2002 May 14;99(10):7130–7135.
  • Dani M, Guindon J, Lambert C, et al. The local antinociceptive effects of paracetamol in neuropathic pain are mediated by cannabinoid receptors. Eur J Pharmacol. 2007 Nov 14;573(1–3):214–215.
  • Ladd J. How much is too much? Acetaminophen overuse in the United States. Pharmacy Today. 2018;24(11):24.
  • Whyte IM, Buckley NA, Reith DM, et al. Acetaminophen causes an increased international normalized ratio by reducing functional factor VII. Ther Drug Monit. 2000 Dec;22(6):742–748.
  • Parra D, Beckey NP, Stevens GR. The effect of acetaminophen on the international normalized ratio in patients stabilized on warfarin therapy. Pharmacotherapy. 2007 May;27(5):675–683.
  • Miners JO, Attwood J, Birkett DJ. Determinants of acetaminophen metabolism: effect of inducers and inhibitors of drug metabolism on acetaminophen’s metabolic pathways. Clin Pharmacol Ther. 1984 Apr;35(4):480–486.
  • Perucca E, Richens A. Paracetamol disposition in normal subjects and in patients treated with antiepileptic drugs. Br J Clin Pharmacol. 1979 Feb;7(2):201–206.
  • Depot M, Powell JR, Messenheimer JA Jr., et al. Kinetic effects of multiple oral doses of acetaminophen on a single oral dose of lamotrigine. Clin Pharmacol Ther. 1990 Oct;48(4):346–355.
  • Gastrup S, Stage TB, Fruekilde PB, et al. Paracetamol decreases steady-state exposure to lamotrigine by induction of glucuronidation in healthy subjects. Br J Clin Pharmacol. 2016 Apr;81(4):735–741.
  • Carnovale C, Mosini G, Gringeri M, et al. Interaction between paracetamol and lamotrigine: new insights from the FDA adverse event reporting system (FAERS) database. Eur J Clin Pharmacol. 2019 Sep;75(9):1323–1325.
  • Liu Y, Ramirez J, Ratain MJ. Inhibition of paracetamol glucuronidation by tyrosine kinase inhibitors. Br J Clin Pharmacol. 2011 Jun;71(6):917–920.
  • Becker DE. Pain management: part 1: managing acute and postoperative dental pain. Anesth Prog. 2010;57(2):67–78. Summer Summer. DOI:10.2344/0003-3006-57.2.67
  • Cashman JN. The mechanisms of action of NSAIDs in analgesia. Drugs. 1996;52 Suppl 5:13–23.
  • Catella-Lawson F, Reilly MP, Kapoor SC, et al. Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. N Engl J Med. 2001 Dec 20;345(25):1809–1817.
  • Mazaleuskaya LL, Theken KN, Gong L, et al. PharmGKB summary: ibuprofen pathways. Pharmacogenet Genomics. 2015 Feb;25(2):96–106. DOI:10.1097/FPC.0000000000000113
  • Radack KL, Deck CC, Bloomfield SS. Ibuprofen interferes with the efficacy of antihypertensive drugs. A randomized, double-blind, placebo-controlled trial of ibuprofen compared with acetaminophen. Ann Intern Med. 1987 Nov;107(5):628–635.
  • Rainsford KD. Ibuprofen: pharmacology, efficacy and safety. Inflammopharmacology. 2009 Dec;17(6):275–342.
  • El-Yazbi AF, Eid AH, El-Mas MM. Cardiovascular and renal interactions between cyclosporine and NSAIDs: underlying mechanisms and clinical relevance. Pharmacol Res. 2018 Mar;129:251–261.
  • Brouwers JR, de Smet PA. Pharmacokinetic-pharmacodynamic drug interactions with nonsteroidal anti-inflammatory drugs. Clin Pharmacokinet. 1994 Dec;27(6):462–485.
  • Medexus Pharma, Inc. Rasuvo (methotrexate) prescribing information. (last accessed 2023 Apr 23) Available at: https://www.rasuvo.com/pdf/prescribing-information.pdf
  • Svanstrom H, Lund M, Melbye M, et al. Concomitant use of low-dose methotrexate and NSAIDs and the risk of serious adverse events among patients with rheumatoid arthritis. Pharmacoepidemiol Drug Saf. 2018 Aug;27(8):885–893.
  • Tracy TS, Krohn K, Jones DR, et al. The effects of a salicylate, ibuprofen, and naproxen on the disposition of methotrexate in patients with rheumatoid arthritis. Eur J Clin Pharmacol. 1992;42(2):121–125. DOI:10.1007/BF00278469
  • Hall JJ, Bolina M, Chatterley T, et al. Interaction between low-dose methotrexate and nonsteroidal anti-inflammatory drugs, penicillins, and proton pump inhibitors. Ann Pharmacother. 2017 Feb;51(2):163–178.
  • Ragheb M. Ibuprofen can increase serum lithium level in lithium-treated patients. J Clin Psychiatry. 1987 Apr;48(4):161–163.
  • Gudin JA, Mogali S, Jones JD, et al. Risks, management, and monitoring of combination opioid, benzodiazepines, and/or alcohol use. Postgrad Med. 2013 Jul;125(4):115–130.
  • Rogers E, Mehta S, Shengelia R, et al. Four strategies for managing opioid-induced side effects in older adults. Clin Geriatr. 2013 Apr;21(4):1–14.
  • Chen A, Ashburn MA. Cardiac effects of opioid therapy. Pain Med. 2015 Oct;16(Suppl 1):S27–31.
  • Tori ME, Larochelle MR, Naimi TS. Alcohol or benzodiazepine co-involvement with opioid overdose deaths in the United States, 1999-2017. JAMA Netw Open 2020 Apr 1;3(4):e202361.
  • Overholser BR, Foster DR. Opioid pharmacokinetic drug-drug interactions. Am J Manag Care. 2011 Sep;17(Suppl 11):S276–287.
  • Feng XQ, Zhu LL, Zhou Q. Opioid analgesics-related pharmacokinetic drug interactions: from the perspectives of evidence based on randomized controlled trials and clinical risk management. J Pain Res. 2017;10:1225–1239.
  • Klinger-Gratz PP, Ralvenius WT, Neumann E, et al. Acetaminophen relieves inflammatory pain through cb1 cannabinoid receptors in the rostral ventromedial medulla. J Neurosci. 2018 Jan 10;38(2):322–334.
  • Pickering G, Loriot MA, Libert F, et al. Analgesic effect of acetaminophen in humans: first evidence of a central serotonergic mechanism. Clin Pharmacol Ther. 2006 Apr;79(4):371–378.
  • Stockler M, Vardy J, Pillai A, et al. Acetaminophen (paracetamol) improves pain and well-being in people with advanced cancer already receiving a strong opioid regimen: a randomized, double-blind, placebo-controlled cross-over trial. J Clin Oncol. 2004 Aug 15;22(16):3389–3394. DOI:10.1200/JCO.2004.09.122
  • Zygmunt PM, Chuang H, Movahed P, et al. The anandamide transport inhibitor AM404 activates vanilloid receptors. Eur J Pharmacol. 2000 May 12;396(1):39–42.
  • De Petrocellis L, Bisogno T, Davis JB, et al. Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity. FEBS Lett. 2000 Oct 13;483(1):52–56.
  • Weiss NS. Use of acetaminophen in relation to the occurrence of cancer: a review of epidemiologic studies. Cancer Causes Control. 2016 Dec;27(12):1411–1418.
  • Ostapowicz G, Fontana RJ, Schiodt FV, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med. 2002 Dec 17;137(12):947–954.
  • Bronstein AC, Spyker DA, Cantilena LR Jr., et al. Annual report of the american association of poison control centers’ national poison data system (NPDS). Clin Toxicol (Phila). 2007 Dec;45(8):815–917. 2006. DOI:10.1080/15563650701754763
  • McGill MR, Jaeschke H. Metabolism and disposition of acetaminophen: recent advances in relation to hepatotoxicity and diagnosis. Pharm Res. 2013 Sep;30(9):2174–2187. DOI:10.1007/s11095-013-1007-6
  • Farrell SE, Defendi GL (2020 Jan 17). What are the recommended maximum daily dosages of acetaminophen in adults and children? Medscape. Retrieved 2020 Feb 10 from https://www.medscape.com/answers/820200-27207/what-are-the-recommended-maximum-daily-dosages-of-acetaminophen-in-adults-and-children
  • Vogel J, Heard KJ, Carlson C, et al. Dental pain as a risk factor for accidental acetaminophen overdose: a case-control study. Am J Emerg Med. 2011 Nov;29(9):1125–1129.
  • Mendes D, Alves C, Batel-Marques F. Number needed to treat (NNT) in clinical literature: an appraisal. BMC Med 2017 Jun 1;15(1):112.
  • Altman DG. Confidence intervals for the number needed to treat. BMJ 1998 Nov 7;317(7168):1309–1312.
  • Weil K, Hooper L, Afzal Z, et al. Paracetamol for pain relief after surgical removal of lower wisdom teeth. Cochrane Database Syst Rev. 2007 Jul;18(3): CD004487. DOI:10.1002/14651858.CD004487.pub2
  • Deshpande A, Bhargava D, Gupta M. Analgesic efficacy of acetaminophen for controlling postextraction dental pain. Ann Maxillofac Surg. 2014 Jul;4(2):176–177.
  • Forrest JA, Clements JA, Prescott LF. Clinical pharmacokinetics of paracetamol. Clin Pharmacokinet. 1982 Mar;7(2):93–107.
  • Thummel KE, Slattery JT, Ro H, et al. Ethanol and production of the hepatotoxic metabolite of acetaminophen in healthy adults. Clin Pharmacol Ther. 2000 Jun;67(6):591–599.
  • Pergolizzi JV, Breve F, Magnusson P, et al. Current and emerging COX inhibitors for treating postoperative pain following oral surgery. Expert Opin Pharmacother. 2023 Jan;4:1–12.
  • Arora M, Choudhary S, Singh PK, et al. Structural investigation on the selective COX-2 inhibitors mediated cardiotoxicity: a review. Life Sci. 2020 Apr 3;251:117631.
  • De Broe ME, Elseviers MM. Analgesic nephropathy. N Engl J Med 1998 Feb 12;338(7):446–452.
  • Elseviers MM, De Broe ME. Analgesic abuse in the elderly. Renal Sequelae and Manage Drugs Aging. 1998 May;12(5):391–400.
  • MacDonald TM, Wei L. Effect of ibuprofen on cardioprotective effect of aspirin. Lancet 2003 Feb 15;361(9357):573–574.
  • Li X, Fries S, Li R, et al. Differential impairment of aspirin-dependent platelet cyclooxygenase acetylation by nonsteroidal antiinflammatory drugs. Proc Natl Acad Sci U S A. 2014 Nov 25;111(47):16830–16835.
  • Curtis JP, Wang Y, Portnay EL, et al. Aspirin, ibuprofen, and mortality after myocardial infarction: retrospective cohort study. BMJ. 2003 Dec 6;327(7427):1322–1323.
  • Patel TN, Goldberg KC. Use of aspirin and ibuprofen compared with aspirin alone and the risk of myocardial infarction. Arch Intern Med 2004 Apr 26;164(8):852–856.
  • Cryer B, Berlin RG, Cooper SA, et al. Double-blind, randomized, parallel, placebo-controlled study of ibuprofen effects on thromboxane B2 concentrations in aspirin-treated healthy adult volunteers. Clin Ther. 2005 Feb;27(2):185–191.
  • Antman EM. The aspirin-NSAID interaction: more Data, but a lack of clarity remains. J Am Coll Cardiol 2018 Apr 24;71(16):1752–1754.
  • Maeda A, Tsuruoka S, Kanai Y, et al. Evaluation of the interaction between nonsteroidal anti-inflammatory drugs and methotrexate using human organic anion transporter 3-transfected cells. Eur J Pharmacol. 2008 Oct 31;596(1–3):166–172.
  • Theken KN, Lee CR, Gong L, et al. Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2C9 and nonsteroidal anti-inflammatory drugs. Clin Pharmacol Ther. 2020 Mar 19;108(2):191–200.
  • Daly AK, King BP. Pharmacogenetics of oral anticoagulants. Pharmacogenetics. 2003 May;13(5):247–252.
  • Moore RA, Derry S, Aldington D, et al. Single dose oral analgesics for acute postoperative pain in adults - an overview of Cochrane reviews. Cochrane Database Syst Rev. 2015 Sep;28(9):CD008659. DOI:10.1002/14651858.CD008659.pub3
  • Derry S, Moore RA. Single dose oral celecoxib for acute postoperative pain in adults. Cochrane Database Syst Rev. 2013 Oct;22(10):CD004233.
  • Al-Sukhun J, Al-Sukhun S, Penttila H, et al. Preemptive analgesic effect of low doses of celecoxib is superior to low doses of traditional nonsteroidal anti-inflammatory drugs. J Craniofac Surg. 2012 Mar;23(2):526–529.
  • Akinbade AO, Ndukwe KC, Owotade FJ. Comparative analgesic effects of ibuprofen, celecoxib and tramadol after third molar surgery: a randomized double blind controlled trial. J Contemp Dent Pract 2018 Nov 1;19(11):1334–1340.
  • Hannam JA, Murto KT, Anderson BJ, et al. Modeling adult COX-2 cerebrospinal fluid pharmacokinetics to inform pediatric investigation. Paediatr Anaesth. 2023 Apr;33(4):291–302.
  • Hersh EV, Moore PA, Grosser T, et al. Nonsteroidal Anti-Inflammatory Drugs and Opioids in Postsurgical Dental Pain. J Dent Res. 2020 Apr;14(7):22034520914254.
  • Denisco RC, Kenna GA, O’Neil MG, et al. Prevention of prescription opioid abuse: the role of the dentist. J Am Dent Assoc. 2011 Jul;142(7):800–810.
  • Hersh EV, Saraghi M, Moore PA. The prescription opioid abuse crisis and our role in it. Gen Dent. 2018 Jul;66(4):10–13.
  • Gupta N, Vujicic M, Blatz A. Multiple opioid prescriptions among privately insured dental patients in the United States: evidence from claims data. J Am Dent Assoc. 2018 Jul;149(7):619–627 e611.
  • Hassan HE, Myers AL, Coop A, et al. Differential involvement of P-glycoprotein (ABCB1) in permeability, tissue distribution, and antinociceptive activity of methadone, buprenorphine, and diprenorphine: in vitro and in vivo evaluation. J Pharm Sci. 2009 Dec;98(12):4928–4940.
  • Hassan HE, Myers AL, Lee IJ, et al. Oxycodone induces overexpression of P-glycoprotein (ABCB1) and affects paclitaxel’s tissue distribution in Sprague Dawley rats. J Pharm Sci. 2007 Sep;96(9):2494–2506.
  • Hassan HE, Myers AL, Lee IJ, et al. Induction of xenobiotic receptors, transporters, and drug metabolizing enzymes by oxycodone. Drug Metab Dispos. 2013 May;41(5):1060–1069.
  • Hersh EV, Pinto A, Moore PA. Adverse drug interactions involving common prescription and over-the-counter analgesic agents. Clin Ther. 2007;29 Suppl(11):2477–2497.
  • Crews KR, Gaedigk A, Dunnenberger HM, et al. Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update. Clin Pharmacol Ther. 2014 Apr;95(4):376–382.
  • Smith HS. Opioid metabolism. Mayo Clin Proc. 2009 Jul;84(7):613–624.
  • Bertilsson L, Dahl ML, Dalen P, et al. Molecular genetics of CYP2D6: clinical relevance with focus on psychotropic drugs. Br J Clin Pharmacol. 2002 Feb;53(2):111–122.
  • Kirchheiner J, Schmidt H, Tzvetkov M, et al. Pharmacokinetics of codeine and its metabolite morphine in ultra-rapid metabolizers due to CYP2D6 duplication. Pharmacogenomics J. 2007 Aug;7(4):257–265.
  • Heintze K, Fuchs W. Codeine ultra-rapid metabolizers: age appears to be a key factor in adverse effects of codeine. Drug Res (Stuttg). 2015 Dec;65(12):640–644.
  • Yiannakopoulou E. Pharmacogenomics and opioid analgesics: clinical implications. Int J Genomics. 2015;2015:368979.
  • Schmahl C, Ludascher P, Greffrath W, et al. COMT val158met polymorphism and neural pain processing. PLoS ONE. 2012;7(1):e23658. DOI:10.1371/journal.pone.0023658
  • Yao P, Ding Y-Y, Wang Z-B, et al. Effect of gene polymorphism of COMT and OPRM1 on the preoperative pain sensitivity in patients with cancer. Int J Clin Exp Med. 2015;8(6):10036–10039.
  • Litkowski LJ, Christensen SE, Adamson DN, et al. Analgesic efficacy and tolerability of oxycodone 5 mg/ibuprofen 400 mg compared with those of oxycodone 5 mg/acetaminophen 325 mg and hydrocodone 7.5 mg/acetaminophen 500 mg in patients with moderate to severe postoperative pain: a randomized, double-blind, placebo-controlled, single-dose, parallel-group study in a dental pain model. Clin Ther. 2005 Apr;27(4):418–429. DOI:10.1016/j.clinthera.2005.04.010
  • Grond S, Sablotzki A. Clinical pharmacology of tramadol. Clin Pharmacokinet. 2004;43(13):879–923.
  • Isiordia-Espinoza MA, de Jesus Pozos-Guillen A, Aragon-Martinez OH. Analgesic efficacy and safety of single-dose tramadol and non-steroidal anti-inflammatory drugs in operations on the third molars: a systematic review and meta-analysis. Br J Oral Maxillofac Surg. 2014 Nov;52(9):775–783.
  • Isiordia-Espinoza MA, Sanchez-Prieto M, Tobias-Azua F, et al. Pre-emptive analgesic effectiveness of meloxicam versus tramadol after mandibular third molar surgery: a pilot study. J Oral Maxillofac Surg. 2012 Jan;70(1):31–36.
  • Miroshnychenko A, Ibrahim S, Azab M, et al. Acute postoperative pain due to dental extraction in the adult population: a systematic review and network meta-analysis. J Dent Res. 2023 Apr;102(4):391–401. DOI:10.1177/00220345221139230
  • Abou-Atme YS, Melis M, Zawawi KH. Efficacy and safety of acetaminophen and caffeine for the management of acute dental pain: a systematic review. Saudi Dent J. 2019 Oct;31(4):417–423.
  • Forbes JA, Beaver WT, Jones KF, et al. Effect of caffeine on ibuprofen analgesia in postoperative oral surgery pain. Clin Pharmacol Ther. 1991 Jun;49(6):674–684.
  • McQuay HJ, Angell K, Carroll D, et al. Ibuprofen compared with ibuprofen plus caffeine after third molar surgery. Pain. 1996 Aug;66(2–3):247–251.
  • Weiser T, Richter E, Hegewisch A, et al. Efficacy and safety of a fixed-dose combination of ibuprofen and caffeine in the management of moderate to severe dental pain after third molar extraction. Eur J Pain. 2018 Jan;22(1):28–38.
  • Derry S, Wiffen PJ, Moore RA. Single dose oral ibuprofen plus caffeine for acute postoperative pain in adults. Cochrane Database Syst Rev. 2015 Jul 14;20157:CD011509.
  • Benowitz NL. Clinical pharmacology of caffeine. Annu Rev Med. 1990;41(1):277–288.
  • Baratloo A, Rouhipour A, Forouzanfar MM, et al. The role of caffeine in pain management: a brief literature review. Anesth Pain Med. 2016 Jun;6(3):e33193.
  • Carrillo JA, Benitez J. Clinically significant pharmacokinetic interactions between dietary caffeine and medications. Clin Pharmacokinet. 2000 Aug;39(2):127–153.
  • Healy DP, Polk RE, Kanawati L, et al. Interaction between oral ciprofloxacin and caffeine in normal volunteers. Antimicrob Agents Chemother. 1989 Apr;33(4):474–478.
  • Culm-Merdek KE, von Moltke LL, Harmatz JS, et al. Fluvoxamine impairs single-dose caffeine clearance without altering caffeine pharmacodynamics. Br J Clin Pharmacol. 2005 Nov;60(5):486–493.
  • Jeppesen U, Loft S, Poulsen HE, et al. A fluvoxamine-caffeine interaction study. Pharmacogenetics. 1996 Jun;6(3):213–222.
  • Nehlig A. Interindividual differences in caffeine metabolism and factors driving caffeine consumption. Pharmacol Rev. 2018 Apr;70(2):384–411.
  • Yasaei R, Katta S, Saadabadi A. Gabapentin. StatPearls. Treasure Island (FL) 2022.
  • Pfizer. Neurontin (gabapentin) prescribing information. (last accessed 2023 Feb 13) Available at: http://www.pfizer.com/files/products/uspi_neurontin.pdf
  • Yagi T, Naito T, Mino Y, et al. Impact of concomitant antacid administration on gabapentin plasma exposure and oral bioavailability in healthy adult subjects. Drug Metab Pharmacokinet. 2012;27(2):248–254. DOI:10.2133/dmpk.DMPK-11-RG-108
  • Eckhardt K, Ammon S, Hofmann U, et al. Gabapentin enhances the analgesic effect of morphine in healthy volunteers. Anesth Analg. 2000 Jul;91(1):185–191.
  • Troupin AS, Montouris G, Hussein G. Felbamate: therapeutic range and other kinetic information. J Epilepsy. 1997;10(1):26–31.
  • Quintero GC. Review about gabapentin misuse, interactions, contraindications and side effects. J Exp Pharmacol. 2017;9:13–21.
  • Rose MA, Kam PC. Gabapentin: pharmacology and its use in pain management. Anaesthesia. 2002 May;57(5):451–462.
  • Goodman CW, Brett AS. Gabapentinoids for pain: potential unintended consequences. Am Fam Physician. 2019 Dec 1;100(11):672–675.
  • Weinberg MA, Segelnick SL, Insler JS. Abuse potential of gabapentin in dentistry. Gen Dent. 2017 Nov;65(6):73–75.
  • Gajraj NM. Pregabalin: its pharmacology and use in pain management. Anesth Analg. 2007 Dec;105(6):1805–1815.
  • May TW, Rambeck B, Neb R, et al. Serum concentrations of pregabalin in patients with epilepsy: the influence of dose, age, and comedication. Ther Drug Monit. 2007 Dec;29(6):789–794.
  • Zanos P, Moaddel R, Morris PJ, et al. Ketamine and ketamine metabolite pharmacology: insights into therapeutic mechanisms. Pharmacol Rev. 2018 Jul;70(3):621–660.
  • Esparza-Villalpando V, Ascencio-Padilla R, Pozos-Guillen A, et al. Local ketamine improves postoperative analgesia after third molar surgery. J Oral Maxillofac Surg. 2019 Dec;77(12):2386–2400. DOI:10.1016/j.joms.2019.07.002
  • Peltoniemi MA, Hagelberg NM, Olkkola KT, et al. Ketamine: a review of clinical pharmacokinetics and pharmacodynamics in anesthesia and pain therapy. Clin Pharmacokinet. 2016 Sep;55(9):1059–1077.
  • Satilmis T, Garip H, Arpaci E, et al. Assessment of combined local anesthesia and ketamine for pain, swelling, and trismus after surgical extraction of third molars. J Oral Maxillofac Surg. 2009 Jun;67(6):1206–1210.
  • Kumar A, Kale TP. A comparative study between the effect of combined local anesthetic and low-dose ketamine with local anesthetic on postoperative complications after impacted third molar surgery. J Contemp Dent Pract 2015 Dec 1;16(12):957–962.
  • Brinck EC, Tiippana E, Heesen M, et al. Perioperative intravenous ketamine for acute postoperative pain in adults. Cochrane Database Syst Rev. 2018 Dec 20;12(12): CD012033. DOI:10.1002/14651858.CD012033.pub4
  • Hirshman CA, Krieger W, Littlejohn G, et al. Ketamine-aminophylline-induced decrease in seizure threshold. Anesthesiology. 1982 Jun;56(6):464–467.
  • Straube S, Derry S, Moore RA, et al. Single dose oral gabapentin for established acute postoperative pain in adults. Cochrane Database Syst Rev. 2010 May 12;2010(5):CD008183.
  • Huang Q, Rasubala L, Gracely RH, et al. Comparison of analgesic prescriptions for dental pain and patient pain outcomes before vs after an opioid reduction initiative. JAMA Netw Open. 2022 Aug 1;5(8):e2227219. DOI:10.1001/jamanetworkopen.2022.27219
  • Hill CM, Balkenohl M, Thomas DW, et al. Pregabalin in patients with postoperative dental pain. Eur J Pain. 2001;5(2):119–124. DOI:10.1053/eujp.2001.0235
  • Olmedo-Gaya MV, Manzano-Moreno FJ, Galvez-Mateos R, et al. Oral pregabalin for postoperative pain relief after third molar extraction: a randomized controlled clinical trial. Clin Oral Investig. 2016 Sep;20(7):1819–1826. DOI:10.1007/s00784-015-1657-3
  • Pavan R, Jain S, Shraddha, et al. Properties and therapeutic application of bromelain: a review. Biotechnol Res Int. 2012;2012:976203.
  • Isola G, Matarese M, Ramaglia L, et al. Efficacy of a drug composed of herbal extracts on postoperative discomfort after surgical removal of impacted mandibular third molar: a randomized, triple-blind, controlled clinical trial. Clin Oral Investig. 2019 May;23(5):2443–2453.
  • Gupta AA, Kambala R, Bhola N, et al. Comparative efficacy of bromelain and aceclofenac in limiting post-operative inflammatory sequelae in surgical removal of lower impacted third molar: a randomized controlled, triple blind clinical trial. J Dent Anesth Pain Med. 2022 Feb;22(1):29–37.
  • Inchingolo F, Tatullo M, Marrelli M, et al. Clinical trial with bromelain in third molar exodontia. Eur Rev Med Pharmacol Sci. 2010 Sep;14(9):771–774.
  • Majid OW, Al-Mashhadani BA. Perioperative bromelain reduces pain and swelling and improves quality of life measures after mandibular third molar surgery: a randomized, double-blind, placebo-controlled clinical trial. J Oral Maxillofac Surg. 2014 Jun;72(6):1043–1048.
  • de la Barrera-Nunez MC, Yanez-Vico RM, Batista-Cruzado A, et al. Prospective double-blind clinical trial evaluating the effectiveness of Bromelain in the third molar extraction postoperative period. Med Oral Patol Oral Cir Bucal. 2014 Mar 1;19(2):e157–162.
  • de Souza GM, Fernandes IA, Dos Santos CRR, et al. Is bromelain effective in controlling the inflammatory parameters of pain, edema, and trismus after lower third molar surgery? A systematic review and meta-analysis. Phytother Res. 2019 Mar;33(3):473–481.
  • Liu S, Zhao H, Wang Y, et al. Oral bromelain for the control of facial swelling, trismus, and pain after mandibular third molar surgery: a systematic review and meta-analysis. J Oral Maxillofac Surg. 2019 Aug;77(8):1566–1574.
  • Mendes ML, Do Nascimento-Junior EM, Reinheimer DM, et al. Efficacy of proteolytic enzyme bromelain on health outcomes after third molar surgery. Systematic review and meta-analysis of randomized clinical trials. Med Oral Patol Oral Cir Bucal. 2019 Jan 1;24(1):e61–69.
  • Galeotti N. Hypericum perforatum (St John’s wort) beyond depression: a therapeutic perspective for pain conditions. J Ethnopharmacol. 2017 Mar 22;200:136–146. DOI:10.1016/j.jep.2017.02.016
  • Borrelli F, Izzo AA. Herb-drug interactions with St John’s wort (Hypericum perforatum): an update on clinical observations. Aaps J. 2009 Dec;11(4):710–727.
  • Kumarswamy A. Multimodal management of dental pain with focus on alternative medicine: a novel herbal dental gel. Contemp Clin Dent. 2016 Apr;7(2):131–139.
  • Hamid MA. Low-level laser therapy on postoperative pain after mandibular third molar surgery. Ann Maxillofac Surg. 2017 Jul;7(2):207–216.
  • Eshghpour M, Ahrari F, Takallu M. Is low-level laser therapy effective in the management of pain and swelling after mandibular third molar surgery? J Oral Maxillofac Surg. 2016 Jul;74(7):1322 e1321–1328. DOI:10.1016/j.joms.2016.02.030
  • He WL, Yu FY, Li CJ, et al. A systematic review and meta-analysis on the efficacy of low-level laser therapy in the management of complication after mandibular third molar surgery. Lasers Med Sci. 2015 Aug;30(6):1779–1788.
  • Ong CK, Lirk P, Seymour RA, et al. The efficacy of preemptive analgesia for acute postoperative pain management: a meta-analysis. Anesth Analg. 2005 Mar;100(3):757–773. table of contents. DOI:10.1213/01.ANE.0000144428.98767.0E
  • Cetira Filho EL, Carvalho FSR, de Barros Silva PG, et al. Preemptive use of oral nonsteroidal anti-inflammatory drugs for the relief of inflammatory events after surgical removal of lower third molars: a systematic review with meta-analysis of placebo-controlled randomized clinical trials. J Craniomaxillofac Surg. 2020 Mar;48(3):293–307.
  • Dionne RA, Campbell RA, Cooper SA, et al. Suppression of postoperative pain by preoperative administration of ibuprofen in comparison to placebo, acetaminophen, and acetaminophen plus codeine. J Clin Pharmacol. 1983 Jan;23(1):37–43.
  • Williams DM. Clinical Pharmacology of Corticosteroids. Respir Care. 2018 Jun;63(6):655–670.
  • Kim K, Brar P, Jakubowski J, et al. The use of corticosteroids and nonsteroidal antiinflammatory medication for the management of pain and inflammation after third molar surgery: a review of the literature. Oral Surg, Oral Med Oral Pathol Oral Radiol Endod. 2009 May;107(5):630–640.
  • Wagner JC, Johnson TM, Gilbert WA. Should periodontists prescribe postoperative oral corticosteroids to control pain and swelling? A systematic review. Clin Adv Periodontics. 2022 Jun;12(2):134–142.
  • Sugragan C, Sirintawat N, Kiattavornchareon S, et al. Do corticosteroids reduce postoperative pain following third molar intervention? J Dent Anesth Pain Med. 2020 Oct;20(5):281–291. DOI:10.17245/jdapm.2020.20.5.281
  • Lim D, Ngeow WC. A comparative study on the efficacy of submucosal injection of dexamethasone versus methylprednisolone in reducing postoperative sequelae after third molar surgery. J Oral Maxillofac Surg. 2017 Nov;75(11):2278–2286.
  • Falci SGM, Lima TC, Martins CC, et al. Preemptive effect of dexamethasone in third-molar surgery: a meta-analysis. Anesth Prog. 2017;64(3):136–143. DOI:10.2344/anpr-64-05-08
  • Almeida RAC, Lemos CAA, de Moraes SLD, et al. Efficacy of corticosteroids versus placebo in impacted third molar surgery: systematic review and meta-analysis of randomized controlled trials. Int J Oral Maxillofac Surg. 2019 Jan;48(1):118–131.
  • Ngeow WC, Lim D. Do corticosteroids still have a role in the management of third molar surgery? Adv Ther. 2016 Jul;33(7):1105–1139.
  • Saraghi M, Hersh EV. Three newly approved analgesics: an update. Anesth Prog. 2013;60(4):178–187. Winter. DOI:10.2344/0003-3006-60.4.178
  • Bultema K, Fowler S, Drum M, et al. Pain reduction in untreated symptomatic irreversible pulpitis using liposomal bupivacaine (exparel): a prospective, randomized, double-blind trial. J Endod. 2016 Dec;42(12):1707–1712.
  • Lieblich SE, Misiek D, Olczak J, et al. A retrospective cross-sectional study of the effect of liposomal bupivacaine on postoperative opioid prescribing after third molar extraction. J Oral Maxillofac Surg. 2021 Jul;79(7):1401–1408. e1401. DOI:10.1016/j.joms.2021.02.012
  • Kumar SS A commentary on: effect of liposomal bupivacaine on postoperative opioid prescribing after third molar extraction. PracticeUpdate website. Accessed 2023 Feb 2. Available at: https://www.practiceupdate.com/content/effect-of-liposomal-bupivacaine-on-postoperative-opioid-prescribing-after-third-molar-extraction/114282
  • Lieblich SE, Danesi H. Liposomal bupivacaine use in third molar impaction surgery: innovate study. Anesth Prog. 2017;64(3):127–135. Fall. DOI:10.2344/anpr-64-02-03
  • Ji YD, Harris JA, Gibson LE, et al. The efficacy of liposomal bupivacaine for opioid and pain reduction: a systematic review of randomized clinical trials. J Surg Res. 2021 Aug;264:510–533. DOI:10.1016/j.jss.2021.02.024
  • Cheung CW, Choi WS, Leung YY, et al. A double-blind randomized crossover study to evaluate the timing of pregabalin for third molar surgery under local anesthesia. J Oral Maxillofac Surg. 2012 Jan;70(1):25–30.
  • Degirmenci A, Yalcin E. The effect of pregabalin and ibuprofen combination for pain after third molar surgery. Niger J Clin Pract. 2019 Apr;22(4):503–510.
  • Keith DA, Hernandez-Nuno de la Rosa MF. Special screening resources: strategies to identify substance use disorders, including opioid misuse and abuse. Dent Clin North Am. 2020 Jul;64(3):513–524. DOI:10.1016/j.cden.2020.03.002
  • Keith DA, Kulich RJ, Vasciannie AA, et al. Opioid Prescribing in Dental Practice: managing Liability Risks. Dent Clin North Am. 2020 Jul;64(3):597–608.
  • Scrivani SJ, Keith DA, Kulich RJ, et al. Pain management for dental medicine in 2021: opioids, coronavirus and beyond. J Pain Res. 2021;14:1371–1387.
  • Beakley BD, Kaye AM, Kaye AD. Tramadol, pharmacology, side effects, and serotonin syndrome: a review. Pain Physician. 2015 Jul;18(4):395–400.
  • Wang TT, Nadella S, Lee CC, et al. Do patterns of opioid prescriptions to medicare beneficiaries differ between oral and maxillofacial surgeons practicing in urban and rural settings? J Oral Maxillofac Surg. 2022 Apr;80(4):614–619.
  • Patel NA, Keith DA. Five-year comparative analysis of medicare opioid prescription volume among oral and maxillofacial surgeons. J Oral Maxillofac Surg. 2019 Dec;77(12):2439–2446.
  • Resnick CM, Calabrese CE, Afshar S, et al. Do oral and maxillofacial surgeons over-prescribe opioids after extraction of asymptomatic third molars? J Oral Maxillofac Surg. 2019 Jul;77(7):1332–1336. DOI:10.1016/j.joms.2019.02.011
  • Antithrombotic Trialists C. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002 Jan 12;324(7329): 71–86. DOI:10.1136/bmj.324.7329.71
  • Affairs ADACoS. Jeske AH, Suchko GD, et al. Lack of a scientific basis for routine discontinuation of oral anticoagulation therapy before dental treatment. J Am Dent Assoc. 2003 Nov;134(11):1492–1497. DOI:10.14219/jada.archive.2003.0080
  • Lillis T, Ziakas A, Koskinas K, et al. Safety of dental extractions during uninterrupted single or dual antiplatelet treatment. Am J Cardiol. 2011 Oct 1;108(7):964–967.
  • Hatfield E, Phillips K, Swidan S, et al. Use of low-dose naltrexone in the management of chronic pain conditions: a systematic review. J Am Dent Assoc. 2020 Dec;151(12):891–902 e891.
  • Kutlu Yalcin E, Araujo-Duran J, Turan A. Emerging drugs for the treatment of postsurgical pain. Expert Opin Emerg Drugs. 2021 Dec;26(4):371–384.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.